Please provide your email address to receive an email when new articles are posted on . “Already, we are seeing patients, who would otherwise likely have untreatable and end-stage disease, entering ...

This transcript has been edited for clarity. Joseph Mikhael, MD: Hello. My name is Dr Joseph Mikhael and welcome to Medscape InDiscussion: Multiple Myeloma. Today we're talking about triple-class ...

To address symptoms from myeloma that is resistant to treatment, education and communication with care teams are key. Patients with triple-class refractory multiple myeloma (when the disease does not ...

Please provide your email address to receive an email when new articles are posted on . Novel therapies and treatment strategies could help to address the clinical challenges of triple-class ...

Dr. Elie Fahed explains Beth’s diagnosis of triple-class refractory multiple myeloma and targeted therapy, and Beth recalls symptoms and side effects she experienced. Elie Fahed, MD: Beth, let’s go ...

Patients with multiple myeloma exhibiting poor prognostic features, such as high-risk cytogenetics, soft-tissue plasmacytoma, ISS stage III disease, and triple-class exposure, experienced significant ...

Real-world treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A retrospective chart study. Most common treatment ...

Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial Patients with RRMM refractory to pomalidomide ...